Hualan Biological Bacterin Inc. (301207.SZ)
CNY 18.51
(0.16%)
CNY 18.51
(0.16%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 7.99 Billion CNY | 13.0% |
| 2022 | 7.07 Billion CNY | 56.42% |
| 2021 | 4.52 Billion CNY | 24.0% |
| 2020 | 3.64 Billion CNY | 103.33% |
| 2019 | 1.79 Billion CNY | 31.14% |
| 2018 | 1.36 Billion CNY | 61.77% |
| 2017 | 845.68 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 7.25 Billion CNY | -7.04% |
| 2024 Q1 | 7.8 Billion CNY | -2.33% |
| 2024 Q3 | 7.64 Billion CNY | 5.27% |
| 2023 Q3 | 7.8 Billion CNY | 14.97% |
| 2023 FY | 7.99 Billion CNY | 13.0% |
| 2023 Q4 | 7.99 Billion CNY | 2.4% |
| 2023 Q2 | 6.79 Billion CNY | -4.38% |
| 2023 Q1 | 7.1 Billion CNY | 0.38% |
| 2022 Q3 | 7.17 Billion CNY | -1.32% |
| 2022 Q2 | 7.26 Billion CNY | 7.76% |
| 2022 Q1 | 6.74 Billion CNY | 49.14% |
| 2022 FY | 7.07 Billion CNY | 56.42% |
| 2022 Q4 | 7.07 Billion CNY | -1.37% |
| 2021 Q1 | 3.76 Billion CNY | 3.33% |
| 2021 Q2 | 3.3 Billion CNY | -12.21% |
| 2021 Q4 | 4.52 Billion CNY | -5.02% |
| 2021 Q3 | 4.76 Billion CNY | 43.91% |
| 2021 FY | 4.52 Billion CNY | 24.0% |
| 2020 Q1 | 1.82 Billion CNY | 0.0% |
| 2020 FY | 3.64 Billion CNY | 103.33% |
| 2020 Q4 | 3.64 Billion CNY | 0.0% |
| 2020 Q2 | 1.82 Billion CNY | 0.0% |
| 2020 Q3 | 3.64 Billion CNY | 100.09% |
| 2019 FY | 1.79 Billion CNY | 31.14% |
| 2018 FY | 1.36 Billion CNY | 61.77% |
| 2017 FY | 845.68 Million CNY | 0.0% |